Category Archives: Vaping

According to a slew of recent headlines, electronic cigarette users (vapers) are more likely than smokers to have a stroke earlier in life. Adults who vape could suffer a stroke at least a decade younger than those who smoke tobacco, MSN reported on Monday. E-cigarette users have a 15% higher risk of stroke at a younger age than traditional tobacco smokers, according to preliminary findings.

Relying on data from the National Health and Nutrition Examination Survey (NHANES) from 2015 to 2018, the researchers identified 79,825 adults with a history of stroke who also smoke and/or vape: 7,756 (9.72%) used e-cigarettes; 48,625 (60.91%) used traditional cigarettes, and 23,444 (39.37%) used both.

The study found that vapers typically suffered a stroke around 48, participants who smokedand vaped (dual users) at 50, while plain ole' smokers experienced a stroke at 59. Thepaper's co-author and chair of the neurology department at Brown University's Warren Alpert Medical School, Dr. Karen Furie,suggested that e-cigarettes aren't as benign as first thought based on the results.

We should always be open to new evidence, and vaping may indeed be more harmful than the existing data show. For now, though, there are several crucial reasons we should be skeptical of this conclusion.

Highlighting the wrong result

First problem: these preliminary findings haven't been published in a journal yet. The authors are scheduled to present their research next week at the American Heart Association's annual meeting, so the data haven't even been released to the public. That prohibits us (as well as the media) from drawing any firm conclusions about the study, though we can make some tentative observations based on the abstract.

While news reports focused on the alleged stroke risk of vaping, here's the most striking conclusion from the study:

Stroke was far more common among traditional cigarette smokers than e-cigarette users or people who used both, 6.75% compared to 1.09% and 3.72%, respectively.

So although vapers and dual-users who suffer strokes tend to have them earlier than smokers, their overall stroke risk is much lower. This makes sense in light of earlier research on vaping and tobacco use. Many studies have showna strong dose-response relationship between smoking and stroke; the fewer cigarettes you smoke, the lower your risk.

Several clinical trials have found that vaping helps smokers cut their cigarette consumption, and smokers who replace some or all of their tobacco use with vaping appear to experience reduced stroke risk. [1] One 2019 clinical trial involving 114 individuals who smoked 15 or more cigarettes daily for at least two years found that switching to vaping (with or without nicotine) led to significant improvement in vascular health within one month ...

Considered alongside these earlier studies, the new AHA presentation, again assuming its results are valid,actually suggests that vaping, while not entirely harmless, reduces stroke risk for smokers. As this August 2017 review noted:

Although Ecs [electronic cigarettes] might pose some cardiovascular risk to users, particularly those with existing cardiovascular disease, the risk is thought to be less than that of cigarette smoking based on qualitative and quantitative comparisons of EC aerosol versus cigarette smoke constituents. The adoption of ECs rather than cigarette smoking might, therefore, result in an overall benefit for public health.

The AHA presenters rightly noted that more research is needed to better evaluate the long-term effects of e-cigarettes and their role in heart and stroke health. But as I've argued previously, many tobacco researchers don't seem to actually believe that statement. Instead of objectively reporting what the data show or don't show, they tend to minimize evidence indicating that vaping offers a public health benefit while trying to link electronic cigarettes to adverse outcomes, however tenuous the association may be.

With a presentation titled E-cigarette users face 15% higher risk of stroke at a younger age than traditional smokers, I think Dr. Furie and her colleagues have unfortunately fallen into that trap.

[Editor's note: The AHA recently announced that the researchers will not present their results.]

[1] Nicotine-containing electronic cigarettes are often defined as tobacco products. That's an erroneous definition because it would also includenicotine gums and patches, which nobody defines as tobacco products.

View post:

Vaping and Stroke Risk: New Study Hypes the Wrong Conclusion - American Council on Science and Health

content

The E-cigarette and Vaping market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, the impact of domestic and global market players like JUUL, Vuse, MarkTen, Blu, Logic, Comp Lyfe, etc., value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The Key Areas That Have Been Focused in the Report:

Get Exclusive Sample of Report on E-cigarette and Vaping market @ https://www.affluencemarketreports.com/industry-analysis/request-sample/1808387/

E-cigarette and Vaping Market Segmentation:

E-cigarette and Vaping market is split by Type and by Application. For the period 2016-2026, the growth among segments provides accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

E-cigarette and Vaping Market Report based on Product Type:

E-cigarette and Vaping Market Report based on Applications:

The key market players for global E-cigarette and Vaping market are listed below:

Get Extra Discount on E-cigarette and Vaping Market Report, If your Company is Listed in Above Key Players List @ https://www.affluencemarketreports.com/industry-analysis/request-discount/1808387/

Promising Regions & Countries Mentioned in E-cigarette and Vaping Market Report:

TABLE OF CONTENTS INCLUDE

Consumption Forecast, Market Opportunities & Challenges, Risks and Influences Factors Analysis, Market Size by Application, Market Size by Manufacturers, Market Size by Type, E-cigarette and Vaping Consumption by Regions, E-cigarette and Vaping Production by Regions, Production Forecasts, Value Chain and Sales Channels Analysis, Key Findings in the Global E-cigarette and Vaping Study, Manufacturers Profiles

Report Customization: Clients can request for customization of report as per their need for additional data.

CONTACT FOR ADDITIONAL CUSTOMIZATION @ https://www.affluencemarketreports.com/industry-analysis/request-inquiry/1808387/

Impact of COVID-19 on E-cigarette and Vaping Market

The report also contains the effect of the ongoing worldwide pandemic, i.e., COVID-19, on the E-cigarette and Vaping Market and what the future holds for it. It offers an analysis of the impacts of the epidemic on the international Market. The epidemic has immediately interrupted the requirement and supply series. The E-cigarette and Vaping Market report also assesses the economic effect on firms and monetary markets. Futuristic Reports has accumulated advice from several delegates of this business and has engaged from the secondary and primary research to extend the customers with strategies and data to combat industry struggles throughout and after the COVID-19 pandemic.

For More Details on Impact of COVID-19 on E-cigarette and Vaping Market https://www.affluencemarketreports.com/industry-analysis/covid19-request/1808387/

Frequently Asked Questions

About Affluence:

Affluence Market Reports is the next generation of all your research needs with a strong grapple on the worldwide market for industries, organizations, and governments. Our aim is to deliver exemplary reports that meet the definite needs of clients, which offers an adequate business technique, planning, and competitive landscape for new and existing industries that will develop your business needs.

We provide a premium in-depth statistical approach, a 360-degree market view that includes detailed segmentation, key trends, strategic recommendations, growth figures, Cost Analysis, new progress, evolving technologies, and forecasts by authentic agencies.

For more Details Contact Us:

Affluence Market Reports

Contact Person: Mr. Rohit

Phone Number:

U.S: +1-(424) 256-1722

U.K.: +44 1158 88 1333

Email: [emailprotected]

Website: http://www.affluencemarketreports.com

Go here to see the original:

Growth Drivers of E-cigarette and Vaping Market 2020-2026 based on Key Players (JUUL, Vuse, MarkTen, Blu, Logic, Comp Lyfe, etc.), Types and...

Findings from the 2019 Monitoring the Future (MTF) survey demonstrate the appeal of vaping to teens, as seen in the increased prevalence of marijuana use as well as nicotine vaping. Results from the 45th annual MTF survey, a nationally representative sample of eighth, 10th and 12th graders in hundreds of U.S. schools, were announced today by the director of the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, along with the University of Michigan scientist who leads the research team. The self-report survey is given annually to students who respond to questions about their drug use and attitudes.

Past year vaping of marijuana, which has more than doubled in the past two years, was reported at 20.8% among 12th graders, with 10th graders not far behind at 19.4% and eighth graders at 7.0%. Past month marijuana vaping among 12th graders nearly doubled in a single year to 14% from 7.5%the second largest one-year jump ever tracked for any substance in the history of the survey. (The largest was from 2017-2018 with past month nicotine vaping among 12th graders). For the first time, the survey measured daily marijuana vaping, which was reported at 3.5% among 12th graders, 3.0% among 10th graders, and 0.8% among eighth graders. The MTF investigators documented more detailed findings on teen vaping of marijuana in a research letter released today in the Journal of the American Medical Association. High rates of nicotine vaping reported in the MTF survey were released in September.

Marijuana continues to be the most commonly used illicit drug by adolescents. After remaining mostly stable for many years, daily use of marijuana went up significantly since 2018 among eighth and 10th gradersnow at 1.3% and 4.8% respectively. However, overall past year marijuana use rates remain steady among teens (35.7% among 12th graders; 28.8% among 10th graders; and 11.8% among eighth graders).

Past year rates of any illicit drug use, other than marijuana, remain relatively low among 12th graders; past year use was 3.6% for LSD; 3.3% for synthetic cannabinoids; 2.2% for both cocaine and MDMA (ecstasy); and 0.4% for heroin. Other drug use, including the misuse of prescription medicines and the use of alcohol as well as tobacco cigarettes, continues to decline.

"We are heartened to see the continuing decline in the use of many drugs, particularly non-medical use of prescription opioids; however, teens are clearly attracted to vaping products, which are often concentrated amounts of drugs disguised as electronic gadgets," said NIDA Director Dr. Nora Volkow. "Their growing popularity threatens to undo years of progress protecting the health of adolescents in the U.S."

To highlight the MTF survey findings, NIDA will post two infographics on its website: one related to vaping and the other on several other drug categories.

The survey, conducted since 1975, is funded by a government grant to the University of Michigan, Ann Arbor and is the only comprehensive, large-scale federal government survey on teen drug use that releases findings the same year the data is collected. In 2019, questions were added on daily vaping to address public health concerns about e-cigarettes and vaping devices. This year, the Food and Drug Administration and the Centers for Disease Control and Prevention (CDC) have warned the public about lung illnesses and deaths related to vaping, with some patients as young as 13. The CDC posts periodic updates and recommendations for the public.

The MTF investigators have published several papers and research letters related to these findings:

Overall, 42,531 students from 396 public and private schools participated in this year's MTF survey. The survey has generally been administered to students in paper form, but investigators have been transitioning to electronic tablets. The survey will be fully electronic by 2020. The survey measures drug, alcohol, and cigarette use and related attitudes in eighth, 10th and 12th graders nationwide. Survey participants generally report their drug use behaviors across multiple time periods: lifetime, past year, past month, and in some cases, daily. NIDA has provided grant funding for the survey since its inception. MTF is funded under grant number DA001411.

For additional information on the MTF Survey, see:

Follow Monitoring the Future 2019 news on Twitter at @NIDANews or join the conversation by using: #MTF2019. Information on all drugs can be found on NIDA's website.

Read the original:

Vaping of marijuana on the rise among teens | National ...

As noble global efforts to reduce smoking rates move into a higher gear with the fast-approaching Ninth Conference of the Parties (COP9) of the World Health Organization Framework Convention on Tobacco Control (WHO FCTC), member countries are running the risk of sacrificing the interests of smokers on the unfounded fear of an explosion in youth vaping.

Scheduled for 8-13 November 2021, COP9 will bring together governments, policymakers and anti-tobacco campaigners from across the world to discuss various ways to reduce smoking within the guidelines of the FCTC. The role of Electronic Nicotine and Non-Nicotine Delivery Systems (ENNDS) within the tobacco harm reduction agenda will also be thrust into the spotlight. Based on published Conference documentation, it is expected that youth vaping will feature prominently in the discussions.

The WHO has frequently raised concerns about the potential of ENNDS to appeal to young people and non-smokers, and act as a gateway to smoking, despite available scientific data not supporting this fear. On the contrary, emerging evidence from Canada, France, the UK and New Zealand seems to show fast declining smoking rates co-incidence with the rise in popularity of ENNDS.

According to 2020 data from Action on Smoking and Health UK (ASH), e-cigarette use remains relatively low amongst young people in the UK. The study reveals that the majority of young people had never smoked nor vaped, and that between 0.8% and 1.3% of young people who had never smoked were current vapers. According to the 2021 National Youth Tobacco Survey conducted by the United States Centre for Disease Control and Prevention (CDCP), teen use of electronic cigarettes fell sharply, marking another year of major declines. The survey, administered between 18 January and 21 May 2021, noted that 11.3% of high school students reported that they currently vape down from 19.6% in 2020 and even lower than the 27.5% reported in 2019. Overall, the evidence seems to indicate that ENNDS use among youth may have been a passing curiosity related to risk-taking behaviour inherent in young people.

While the goal of ensuring that young people do not use ENNDS should never be abandoned, this should be balanced with the need to ensure that adult smokers are not robbed of the opportunity to access reduced-harm alternatives to combustible tobacco. Reputable institutions such as Public Health England (PHE) and the UK Royal College of Physicians have found that ENNDS are 95% less harmful than combustible smoking. ENNDS provide a breakthrough in tobacco harm reduction and to some extent, smoking cessation. The Cochrane Library found that ENNDS are a more effective smoking cessation tool than Nicotine Replacement Therapies (NRTs).

Regrettably, the overwhelming evidence in favour of ENNDS has not been enough to convince the WHO otherwise. Instead, the world body is intent on regulatory guidelines that will effectively deny smokers access to information about less harmful alternatives.

Youth vaping can be curbed through practical measures to discourage access and embark on education and awareness campaigns to teach young people about nicotine addiction and that vapes are not completely harmless, even though it is significantly less harmful compared to tobacco smoking. In South Africa, for example, the Vaping Products Association South Africa (VPASA) has taken the initiative to have its members sign a code of conduct and pledge not to sell vaping products to young people under the age of 18.

As the COP9 nears, it is important for the WHO and governments to ensure that they conduct a fair and balanced evaluation of the available evidence to support the development of appropriate ENNDS regulations. While there remains a genuine need to ensure that young people do not take up vaping, it would be a huge disservice to the WHOs tobacco control agenda if ENNDS regulatory guidelines are developed based on ideology and instinct rather than scientific evidence. Ultimately, a non-scientific approach to regulating ENNDS will come at the expense of adult smokers looking for a less harmful alternative to smoking.

Read the rest here:

Preventing Youth Vaping At The Expense Of Smokers - Africa.com

10 November 2021

Oblon, McClelland, Maier & Neustadt, L.L.P

To print this article, all you need is to be registered or login on Mondaq.com.

On November 4, 2021, the ITC issued aNotice ofInvestigationinCertain Oil-Vaping Cartridges,Components Thereof, and Products Containing the Same(Inv. No. 337-TA-1286).

By way of background, this investigation is based on an October4, 2021complaintfiled by Shenzhen SmooreTechology Limited of China ("Smoore") alleging aviolation of section 337 by 38 respondents in the U.S., Canada, andHong Kong in the unlawful importation and/or sale in the U.S. ofcertain oil-vaping cartridges, components thereof, and productscontaining the same by reason of infringement of (1) certain claimsof Patent No. 10,357,623 ("the '623 patent"); U.S.Patent No. 10,791,763 ("the '763 patent"); U.S.Patent No. 10,791,762 ("the '762 patent"); and U.S.Registered Trademark No. 5,633,060 ("the '060mark").

According to the complaint, the '623 patent relatesgenerally to a vaporizer/atomizer device, which includes a liquidstorage cavity, where that cavity expressly excludes the presenceof a wick or other liquid-storage medium; the '763 patentrelates generally to a vaporizer/atomizer device, which includes aliquid storage cavity open at a mouthpiece end to the outsidebefore a mouthpiece is installed; and the '762 patent relatesgenerally to an electronic cigarette that includes avaporizer/atomizer assembly and a liquid storage cavity. The'060 mark is a standard character CCELL mark under which Smooremarkets, advertises, and sells vaporizer products, such aselectronic cigarettes, oral vaporizers for smokers, and vaporizescartridges. The accused products are atomizers, cartridges,mouthpieces, vaporizers, and vaping products used to inhalecannabidiol ("CBD") and/or marinal("THC"). Smoore is requesting that the Commissionissue limited exclusion orders and permanent cease-and-desistorders directed to respondents. According to the Notice ofInvestigation, the Office of Unfair Import Investigations willparticipate as a party in the investigation. Lastly, ChiefALJ Charles E. Bullock issued anoticeindicating that ALJ Clark S. Cheneywill preside in the investigation.

The content of this article is intended to provide a generalguide to the subject matter. Specialist advice should be soughtabout your specific circumstances.

POPULAR ARTICLES ON: Intellectual Property from United States

Obhan & Associates

Trademarks Comparative Guide for the jurisdiction of India, check out our comparative guides section to compare across multiple countries

Milbank LLP

The article also examines the 30 Federal Circuit cases, including their exemplary patent claims, that found eligibility upon Alice challenges.

Excerpt from:

ITC Institutes Investigation (337-TA-1286) In Certain Oil-Vaping Cartridges - Intellectual Property - United States - Mondaq News Alerts

Smokers on psychotropic drugs tend to need higher doses of nicotine.

Research has also indicated that nicotine also alters the coping mechanism in the brain increasing sensitivity to stress. This creates a vicious cycle meaning that this sensitivity is increased as nicotine is consumed in higher doses, which in turns leads to more nicotine consumption.

In fact, data keep indicating that mental health patients are more likely to smoke than individuals who do not suffer from psychological or psychiatric conditions. Moreover, these individuals are more likely to find it harder to quit. To this effect, they benefit greatly from having extra support in relation to smoking cessation and access to safer alternatives, that would at least lessen the chances of them also suffering from smoke-related conditions.

On the other hand, a recent report by former stop-smoking service manager in the UK, Louise Ross, the third in a series of five, said that nicotine is not what kills smokers and highlighted the importance of improving the understanding that e-cigarettes are substantially safer than smoking, and can be used to help smokers quit.

She added that nurses are in an especially good position to promote smoking cessation. Given that studies have indicated that smokers respond well to intensive smoking cessation treatments that are tailor made for their needs, explained Ross, nurses who understand individual patients needs are ideally placed to give ongoing smoking cessation support.

Moreover, she underlined, smokers on psychotropic drugs tend to need higher doses of nicotine. The tar (and not the nicotine) in tobacco smoke also increases the need for higher doses of some psychotropic medications, so stopping smoking enables some people to be prescribed a lower dose and experience fewer side-effects (NCSCT, 2018).

The Link Between Smoking, Vaping and Psychological Well-Being in the US

Original post:

The Relationship Between Vaping and Mental Health - Vaping Post

In 2019 there was a different pandemic sweeping the nation, wreaking havoc on peoples lungs, putting some in the hospital and others in early graves.

Rates of the mysterious E-cigarette or Vaping-product Associated Lung Illness (aka EVALI) spiked in August of 2019 and the Centers for Disease Control and Prevention (CDC) launched an investigation into the outbreak the same month. As of February 18, 2020 (when they stopped recording cases), EVALI had hospitalized 2,807 people68 of whom had died as a result. By September, CDC officials were holding press conferences suggesting that THC products were largely behind the outbreak.

Fingers were pointed, blame was cast, both federal and local legislation started passing to restrict the sale of vape products, and criticisms were levelled against state cannabis policies.

But that blame was misplaced, according to Abigail Friedman, lead author of a study published in, [[I]]Addiction[[I]], titled Association of vaping-related lung injuries with rates of e-cigarette and cannabis use across US states. Her research indicates that the root cause of EVALI actually wasnt correlated to legalized cannabis or higher rates of nicotine vape use at all. In fact, she found the correlation went the opposite direction: States with legal cannabis (and higher rates of vape use) were seeing [[I]]fewer[[I]] cases of EVALI than states upholding prohibition.

This suggests that the problem was tied to illicit or informally sourced productsnot those coming from commercial manufactures.

For her analysis, Friedman collected data from every state on the total number of EVALI cases theyd reported as of the second week of January 2020. She then compared those against state policies concerning cannabis legalization and vape restrictions, prior to August 1 (the day when the CDC initiated its formal investigation into EVALI).

I wanted to look at policies that couldnt possibly have been passed in response to the outbreak because they preceded the CDCs recognition that something was going wrong in the greater public, she says.

Friedman explains that vaporizing cannabis is the second most popular form of cannabis consumption (smoking flower being the first), meaning states with legal cannabis have overall higher rates of vape use than those that dont. So if commercial vapes (for either THC or nicotine) were driving the outbreak of EVALI, she would have expected the rates of EVALI hospitalizations to be higher in states where people had access to legal cannabis.

However, that was not what she observed.

There are fewer cases [of EVALI] per capita in states that have recreational marijuana, Friedman states. If [users in those states] are more likely to vape as their primary mode of use, then it had to be that they were less likely to be exposed to a tainted product.

The data backed that up: States with the strictest cannabis laws and vape restrictionslike Utah, North Dakota, Minnesota, Delaware, and Indianaall had some of the highest rates of EVALI hospitalizations in the country. By contrast, the five earliest states to legalize recreational cannabis (Colorado, California, Oregon, Washington, and Alaska) all had less than one EVALI case per 100,000 residents between the ages of 12 and 64.

Friedman also looked at states that allow for medical marijuana patients to grow their own cannabis, compared to those that prohibit home cultivation.

We thought that if [states] permit home cultivation, people would actually show lower rates of vaping and higher rates of smoking marijuana, she says, adding that was exactly what they found. Consequently, if you permit home cultivation, you see a lower EVALI incidence relative to medical marijuana states that prohibit home cultivation.

All of that information, data, and patterns observed seemed to indicate strongly to Friedman that the root source of Americas EVALI outbreaks was not coming from the legal market.

We were dealing with an informally sourced or illicit market product, Friedman says. That is what creates the danger: if its easy to adulterate products on the illicit market, then its more likely that product gets into the hands of someone who uses it and then gets sick.

Instead of legal cannabis or commercial e-cigarettes causing the health crisis, it was actually prohibition policy driving it.

When were talking about drug policy . . . whether its tobacco or marijuana or other products, we need to be thinking about the effects that a policy targeting one thing will have on both the licit and illicit market for those products, Friedman says.

If people have the option to buy reliable cannabis, or commercially produced cannabis concentrate or nicotine cartridges, they typically will, she says. She explains, the phenomenon is known as crowding out wherethe introduction of a new market, forces the old market out via consumer preference. Safer, higher quality cannabis products will always be preferable to consumers.

This outbreak was not about vaping mainstream nicotine or cannabis products. It was never about vaping mainstream products, Friedman says. [Its] about how state regulations are going to affect the illicit market and how thats introducing new risks.

Continue reading here:

Pandemic of the unregulated - Boulder Weekly

Business Wire India

Chinas leading vaping media, Bluehole New Consumption, today published a feature story on recent vaping regulation updates in the UK, the US and Malaysia. As vaping accepted by more and more health regulators, the industry will witness a more concentrated and standardized market.

Here below is the full article in English:

On October 29, 2021, the U.K government agency, Medicines and Healthcare Products Regulatory Agency (MHRA) announced that NHS could soon prescribe e-cigarettes to help tobacco smokers quit, inviting e-cigarette manufacturers to submit products to undergo the same approval process as prescribed medicines. It could make England the first country to prescribe medicinally licensed e-cigarettes. Under such a circumstance, A medically licensed e-cigarette would have to pass even more rigorous safety checks than those required for them to be sold commercially, according to BBC.

On the same day, the Malaysian government announced to impose excise duty on nicotine vapor products. The managing director of British America Tobacco (BAT) Malaysia, Nedal Salem, said this indicates the Malaysian government is looking to legalize nicotine vapor products: Regulation will not only allow vape users access to reduced-risk alternatives to smoking, but also ensure the products used are compliant to quality and safety standards.

Meanwhile, in October, the U.S Food and Drug Administration (FDA) has granted marketing orders for Vuse Solo and accompanying tobacco flavored e-liquid pods, making it the first set of e-cigarette authorized for sale by the FDA.

From the UK to Malaysia and the U.S, E-cigarette is accepted by more and more health regulators around the world as an effective harm-reduction tool to improve public health.

As BAT Malaysia states, regulation could positively accelerate healthy development of the vaping industry for setting higher quality requirements and safety standards for products. Moreover, regulation measures, such as the marketing authorization and prescription evaluation, could be deemed the regulators acknowledgement of the products public health benefits.

Besides, Mitch Zeller, director of the FDA Center for Tobacco Products, said that many of the tobacco product reviews are in final stages, at a virtual conference hosted by the Food and Drug Law Institute on October 27. However, the agency so far has only authorized three products for their substantial evidence of harm reduction while issuing marketing denial orders for 200 thousand products.

Vuse is currently in a lead position to pass the Premarket Tobacco Product Applications (PMTA) process. It showcases that the FDA (and perhaps other regulators) is more likely to trust and approve products made by market leaders for assured public health benefits and reliability proved by sufficient scientific data.

The FDAs rigorous requirements for products are also applied to manufacturers. SMOORE, the worlds largest vaping manufacturer, is the strategic supplier of VUSE. It features PMTA-related non-clinical evaluation capabilities, including physical testing, chemical testing and health risk assessment. Moreover, SMOOREs CNAS tests have alsoexpanded to 134.

As the regulatory framework outlines a higher entry barrier for the industry, the global vaping industry will witness a more standardized and concentrated market where industry leaders, such as BAT and SMOORE, will further strengthen their leading positions. Meanwhile, the whole industry and the supply chain will benefit from such a well-regulated and standardized market in turn.

To read the original article, please visit: https://www.bluehole.com.cn/news/detail/47350

View source version on businesswire.com: https://www.businesswire.com/news/home/20211103006380/en/

Read the original:

Bluehole New Consumption Publishes a Feature Story on Recent Vaping Regulation Updates - IndianWeb2.com

With patented nicotine salt technology, JUUL dominates the e-cigarette market. We reviewed studies of JUUL's nicotine pharmacokinetic profile and studies quantifying nicotine in a JUULpod, emitted in the aerosol and absorbed by users. Examined in eight studies, JUUL's peak nicotine levels were half to three-quarters that of a combustible cigarette in industry-conducted studies with JUUL-nave users, while comparable to or greater than combustible cigarettes in independent studies of experienced e-cigarette users. JUUL Labs reports each 5% (nicotine-by-weight) cartridge contains approximately 40 mg nicotine per pod and is 'approximately equivalent to about 1 pack of cigarettes.' In five independent studies, nicotine in the liquid in a JUULpod ranged from 39.3 to 48.3 mg. Seven studies measured nicotine delivery via vaping-machine generated aerosols, varying in puffing regimes and equipment. One study estimated 68% transfer efficiency to the aerosol, measuring 28.8 mg nicotine per JUULpod. The other studies reported nicotine values ranging from 72 to 164 g/puff. At 200 puffs, this is 14.4-32.8 mg of nicotine per pod with equivalence to 13-30 cigarettes. A study measuring nicotine levels in JUUL users during a 5-day controlled switch found equivalence to 18 cigarettes. One JUULpod appears capable of delivering the nicotine equivalent to smoking about a pack of cigarettes, with variability. In JUUL-nave smokers, JUUL's nicotine boost was lower than that of combustible cigarettes; while in experienced users, JUUL was comparable. Minimising harshness and adaptive to user experience, JUUL's design facilitates initiation to a high nicotine, and ultimately, highly addictive vaping product.

Keywords: addiction; electronic nicotine delivery devices; nicotine.

Link:

Nicotine delivery and cigarette equivalents from vaping a ...

Breadcrumb Trail Links

Although vaping THC cartridges is easier for many cannabis users, vaping concentrates has increased in popularity.

Author of the article:

It seems that vaping cannabis has become just as popular as rolling a blunt or taking a bong hit in recent years. Part of the reason for this may be that there are so many different forms of vaporizing weed. Additionally, vaping cannabis offers a level of convenience thats hard to top.

This advertisement has not loaded yet, but your article continues below.

For people who are just beginning to familiarize themselves with the world of vaping cannabis products, some of the terminology can get confusing. Thats especially the case when determining whether or not its best to go with a vape pen or a wax pen.

While a vape pen can be used with any cartridge having 510 threading, wax pens require users to have their own concentrates to use. Here are some other key differences between vaping cartridges and raw concentrates.

One of the biggest differences between vaping raw concentrates and vaping THC cartridges is the fact that cartridges are essentially plug and play. After affixing it to the battery, users are ready to find the temperature that works for them and begin taking hits from their device.

This advertisement has not loaded yet, but your article continues below.

Concentrates are a different story. To properly vape concentrates, users must apply their concentrates directly into the pen itself, which can leave excess residue behind if not done properly. Another downfall is that sometimes the pen may not burn the concentrates all the way, which leaves behind sticker residue that is difficult to clean.

Although vaping THC cartridges is easier for many cannabis users, vaping concentrates has increased in popularity for good reason. While the primary ingredient in vape cartridges is THC distillate, in the U.S, there are numerous cutting ingredients such as coconut oil and other potentially harmful ingredients like heavy metals.

This advertisement has not loaded yet, but your article continues below.

On the other hand, vaping concentrates offers users the opportunity to consume pure concentrates, free of any additives. The fact that the individual consumers add the concentrate themselves provides more peace of mind that the product being consumed is safer than potentially harmful cartridges.

Since consumers choosing to vape concentrates rather than cartridges are able to use more sophisticated devices, they are often left to do more maintenance than counterparts who use disposable vape pens with 510 threading.

When regularly using a wax pen to vape concentrates, consumers should be aware they will likely need to replace parts of their device, such as the atomizer and the coil. That can be a tricky process depending on the type of wax pen.

Consumers who prefer to vape THC cartridges dont have to worry about much maintenance with their devices since they can simply discard their pen and get a new one once it starts to show signs of decline.

While most people think theres no big difference between vaping concentrates and THC cartridges, there are a few key characteristics that help to tell them apart. This can make life easier when trying to determine whether its best for the user to buy a wax pen that can vaporize concentrates or a vape pen just for cartridges.

This advertisement has not loaded yet, but your article continues below.

We apologize, but this video has failed to load.

The FreshToast.com , a U.S. lifestyle site that contributes lifestyle content and, with their partnership with 600,000 physicians via Skipta, medical marijuana information to The GrowthOp.

Subscribe to Weekend Dispensary , a new weekly newsletter from The GrowthOp.

This advertisement has not loaded yet, but your article continues below.

Sign-up for Weekend Dispensary to get the latest cannabis news and exclusive articles delivered straight to your inbox.

A welcome email is on its way. If you don't see it, please check your junk folder.

The next issue of Weekend Dispensary will soon be in your inbox.

We encountered an issue signing you up. Please try again

Postmedia is committed to maintaining a lively but civil forum for discussion and encourage all readers to share their views on our articles. Comments may take up to an hour for moderation before appearing on the site. We ask you to keep your comments relevant and respectful. We have enabled email notificationsyou will now receive an email if you receive a reply to your comment, there is an update to a comment thread you follow or if a user you follow comments. Visit our Community Guidelines for more information and details on how to adjust your email settings.

More here:

Three differences between vaping cartridges and raw concentrates - The GrowthOp